Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes (redOrbit)

Rate This

1 Star2 Stars3 Stars4 Stars5 Stars
Loading ... Loading ...
yahoo.com

BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ — Spherix Inc.

Read more of this story
Reproduced under the Fair Use exception of 17USC107
avatar
type diabetes
2 years ago